{
    "clinical_study": {
        "@rank": "141154", 
        "arm_group": [
            {
                "arm_group_label": "CON", 
                "arm_group_type": "Sham Comparator", 
                "description": "Patients undergoing double valve replacement (aortic and mitral)."
            }, 
            {
                "arm_group_label": "IPO", 
                "arm_group_type": "Experimental", 
                "description": "Patients undergoing double valve replacement (aortic and mitral) with ischemic postconditioning."
            }
        ], 
        "brief_summary": {
            "textblock": "1. Cardiopulmonary bypass and cardioplegic arrest could regulate expression of microRNAs\n           in patients undergoing double valve replacement (aortic and mitral).\n\n        2. The modulation of myocardial microRNAs by cardiopulmonary bypass and cardioplegic\n           arrest may be  rescued by ischemic postconditioning.\n\n        3. Downstream effectors would also be affected."
        }, 
        "brief_title": "Effects of Ischemic Postconditioning on MicroRNAs in Double Valve Replacement", 
        "condition": [
            "Cardiopulmonary Bypass", 
            "Ischemic Postconditioning"
        ], 
        "condition_browse": {
            "mesh_term": "Ischemia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Consecutive eight patients with rheumatic heart valve disease undergoing elective\n             double valve replacement(aortic and mitral)are considered for participation in this\n             study.\n\n        Exclusion Criteria:\n\n          -  insulin-dependent diabetes mellitus\n\n          -  pulmonary, renal, or hepatic failure\n\n          -  infective valve disease\n\n          -  valve disease with coronary artery disease\n\n          -  hypertension\n\n          -  emergency and reoperations\n\n          -  received aspirin,corticosteroids, or statin preoperatively\n\n          -  received preoperative inotropic support"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "8", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01804283", 
            "org_study_id": "CmiR-001"
        }, 
        "intervention": [
            {
                "arm_group_label": "IPO", 
                "description": "multiple brief ischemic-reperfusion episodes immediately after sustained ischemic insult\nPostconditioning was started at 30 s after aortic cross declamping, and the aorta was re-clamped for 30 s rendering global myocardial ischemia. Meanwhile aortic root suction was established during aortic re-clamping, and thereafter, the aortic clamp was released for 30 s for full myocardial reperfusion. The cycle was repeated three times after cardioplegic arrest.", 
                "intervention_name": "ischemic postconditioning", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": [
                    "CON", 
                    "IPO"
                ], 
                "description": "The double valve replacement is a procedure in which surgery is used to replace diseased aortic and mitral heart valves.", 
                "intervention_name": "double valve replacement", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": [
                    "CON", 
                    "IPO"
                ], 
                "description": "The heart-lung machine is commonly used in open heart surgery including double valve replacement to support the circulation during the operation.", 
                "intervention_name": "heart-lung machine", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": [
                    "CON", 
                    "IPO"
                ], 
                "description": "a surgical instrument used in cardiac surgery to clamp the aorta", 
                "intervention_name": "Aortic cross-clamp", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 3, 2013", 
        "location": {
            "contact": {
                "email": "luo3478@yahoo.cn", 
                "last_name": "Wanjun Luo, MD", 
                "phone": "86-731-89753003"
            }, 
            "facility": {
                "address": {
                    "city": "Changsha", 
                    "country": "China", 
                    "state": "Hunan", 
                    "zip": "410008"
                }, 
                "name": "Xiangya Hospital"
            }, 
            "investigator": {
                "last_name": "Wanjun Luo, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effects of Ischemic Postconditioning on Expression of Apoptosis-related MicroRNAs and Genes in Human Double Valve Replacement", 
        "overall_official": {
            "affiliation": "Xiangya Hospital of Central South University", 
            "last_name": "Wanjun Luo, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "China: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Samples were harvested from all the patients, respectively, before cardiopulmonary bypass and at 5 min after aortic de-clamping. Real-time quantitative stem-loop reverse transcription polymerase chain reaction assay was performed to detect the expression of microRNAs.", 
            "measure": "Change from Baseline in Cardiac MicroRNA Expression", 
            "safety_issue": "No", 
            "time_frame": "before cardiopulmonary bypass and at 5 min after aortic de-clamping"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01804283"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Central South University", 
            "investigator_full_name": "Luo Wanjun", 
            "investigator_title": "Prof.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Expressions of messenger RNAs and proteins were quantified for genes which are regulated by above-detected microRNAs.", 
            "measure": "Change from Baseline in Downstream Gene Expression", 
            "safety_issue": "No", 
            "time_frame": "before cardiopulmonary bypass and at 5 min after aortic de-clamping"
        }, 
        "source": "Central South University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Central South University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}